These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32311993)

  • 1. Correlation study between serum neuro-specific enolase and gastric and colorectal cancers.
    Luo H; Shen K; Sun H; Li R; Wang Z; Xie Z
    Medicine (Baltimore); 2020 Apr; 99(16):e19796. PubMed ID: 32311993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum neuron-specific enolase in gastric adenocarcinoma.
    Luo H; Shen K; Sun H; Li R; Wang Z; Xie Z
    Medicine (Baltimore); 2020 Apr; 99(16):e19829. PubMed ID: 32312004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
    Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
    Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer.
    Gwak HK; Lee JH; Park SG
    Asian Pac J Cancer Prev; 2014; 15(12):4933-8. PubMed ID: 24998567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis.
    Wen Z; Huang Y; Ling Z; Chen J; Wei X; Su R; Tang Z; Wen Z; Deng Y; Hu Z
    Dis Markers; 2020; 2020():4716793. PubMed ID: 33488842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
    Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S
    J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers.
    Wang CX; Zhuang HB; Shi ZS; Qiu CZ; Chen ZX; Tang LF
    Dis Markers; 2021; 2021():8880282. PubMed ID: 33680216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of tumour markers in pleural effusions.
    Volarić D; Flego V; Žauhar G; Bulat-Kardum L
    Biochem Med (Zagreb); 2018 Feb; 28(1):010706. PubMed ID: 29472801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.
    Yang XQ; Chen C; Peng CW; Liu SP; Li Y
    Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control.
    Shang X; Song C; Du X; Shao H; Xu D; Wang X
    Saudi Med J; 2017 Feb; 38(2):204-208. PubMed ID: 28133696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD; Beinert T; Fürst H; Fink U
    Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer.
    Wu H; Wang Q; Liu Q; Zhang Q; Huang Q; Yu Z
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
    Yang Q; Zhang P; Wu R; Lu K; Zhou H
    Dis Markers; 2018; 2018():2082840. PubMed ID: 30364165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
    Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
    Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.